30
Participants
Start Date
January 31, 2006
Primary Completion Date
December 8, 2009
Study Completion Date
July 20, 2023
Fulvestrant
Participants will receive intramuscular injection of fulvestrant as stated in arm description.
Research Site, Torino
Research Site, The Bronx
Research Site, Philadelphia
Research Site, Bordeaux
Research Site, Miami
Research Site, Birmingham
Research Site, Lexington
Research Site, Osnabrück
Research Site, Bron
Research Site, Baton Rouge
Research Site, Paris
Research Site, Salt Lake City
Research Site, Erlangen
Research Site, Moscow
Research Site, Liverpool
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY